Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160054/S136

HeartMate 3 Left Ventricular Assist System

ABBOTT MEDICAL · Decision date Oct 19, 2026

MEDTECHLEDGER EXPLANATIONP160054/S136

What did the FDA decide?

The FDA record for P160054/S136, a 30-Day Notice dated 2026-10-19 with decision OK30, concerns updated manufacturing inspection acceptance criteria for the modular cable ends of the HeartMate 3 Left Ventricular Assist System. The supplement reason is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier, placing the notice within manufacturing and supplier scope rather than clinical scope.

The identifier links this supplement to the original PMA for the HeartMate 3 system; it is not a new approval of the whole device. The stated purpose concerns inspection acceptance criteria for a component, and the record does not specify the prior criteria, the revised values, the testing method or any evidence of safety or effectiveness. The reported purpose is not independent proof of either.

FDA approval order statement

updated manufacturing inspection acceptance criteria for the modular cable ends
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 19, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160054/S136
Regulatory pathway
PMA supplement
Product code
DSQ
Decision code
OK30
Decision date
Oct 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P160054. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160054 · Original PMA

    HeartMate 3 Left Ventricular Assist System

  2. P160054/S134 · Related supplement

    HeartMate 3 Left Ventricular Assist System

  3. P160054/S136 received

    Application receipt date recorded by FDA.

  4. P160054/S136 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P160054. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160054

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalAug 23, 2017FDA
ABBOTT MEDICALPMA supplementSep 9, 2026FDA
HeartMate 3 LVASP160054/S135
ABBOTT MEDICALPMA supplementOct 1, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
AbbottPMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records